Lisa D. Earnhardt - 06 Mar 2025 Form 4 Insider Report for ABBOTT LABORATORIES (ABT)

Role
EVP AND GROUP PRESIDENT
Signature
/s/ Lisa D. Earnhardt by Jessica H. Paik, Attorney-in-Fact
Issuer symbol
ABT
Transactions as of
06 Mar 2025
Net transactions value
-$4,828,397
Form type
4
Filing time
07 Mar 2025, 18:55:17 UTC
Previous filing
04 Mar 2025
Next filing
26 Feb 2026
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ABT Common shares without par value Options Exercise $7,382,704 +91,167 +127% $80.98 163,095 06 Mar 2025 Direct
transaction ABT Common shares without par value Sale $12,199,968 -91,167 -56% $133.82 71,928 06 Mar 2025 Direct
transaction ABT Common shares without par value Options Exercise $16,196 +200 +0.28% $80.98 72,128 07 Mar 2025 Direct
transaction ABT Common shares without par value Sale $27,329 -200 -0.28% $136.64 71,928 07 Mar 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ABT Option (right to buy) Options Exercise $0 -91,167 -100% $0.000000 200 06 Mar 2025 Common shares 91,167 $80.98 Direct F1
transaction ABT Option (right to buy) Options Exercise $0 -200 -100% $0.000000 0 07 Mar 2025 Common shares 200 $80.98 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Employee stock option granted pursuant to the Abbott Laboratories 2017 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.